Development of a new formula overcoming thymus atrophy with concomitantly enhancement of anti-inflammatory effect of dexamethasone

摘要

Development of a new formulation overcoming thymus atrophy with concomitantly enhancement of anti-inflammatory effect of dexamethasone This invention provides a method of preventing and/or treating thymus degeneration comprising administering an effective amount of dihydromyricetin to a subject in need thereof, in which the degeneration is induced by dexamethasone. In one embodiment, the thymus degeneration is induced during the course of treatment of inflammation by dexamethasone. M006.018.DRF 12 Spec v final for NPRUS